Inflammatory Pathways in Diabetes

Low-grade inflammation sustains metabolic dysfunction. Elevated cytokine polarization disrupts insulin signaling. Immune cells release chemokine gradients that worsen tissue sensitivity. Persistent activation of inflammasome complexes accelerates vascular damage. Modulating immune-metabolic crosstalk is essential for reducing long-term complications.

Discussion Segments:

  • Chronic Inflammation Drivers
  • Immune Signal Regulation
  • Anti-Inflammatory Therapies

    Related Conference of Inflammatory Pathways in Diabetes

    July 20-21, 2026

    6th World Congress on Endocrine and Diabetes

    Paris, France
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France
    October 20-21, 2026

    32nd World Diabetes & Heart Congress

    Amsterdam, Netherlands
    October 22-23, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    February 25-26, 2027

    20th International Summit on Diabetes

    London, UK
    March 23-24, 2027

    7th Annual Summit on Diabetes and Endocrinology

    Paris, France
    March 29-30, 2027

    8th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands

    Inflammatory Pathways in Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in